Genetic testing with primary prevention and moral hazard
•A genetic test reveals an individual's probability of developing a disease.•A costly prevention effort allows high-risk agents to decrease this probability.•Effort may or may not be observable by insurers.•Agents are not obliged to take the test, but must disclose its results to insurers.•We s...
Gespeichert in:
Veröffentlicht in: | Journal of health economics 2013-09, Vol.32 (5), p.768-779 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •A genetic test reveals an individual's probability of developing a disease.•A costly prevention effort allows high-risk agents to decrease this probability.•Effort may or may not be observable by insurers.•Agents are not obliged to take the test, but must disclose its results to insurers.•We study when the test is taken and the prevention effort is made.
We develop a model where a genetic test reveals whether an individual has a low or high probability of developing a disease. Testing is not mandatory, but agents have to reveal their test results to the insurers, facing a discrimination risk. A costly prevention effort allows agents with a genetic predisposition to decrease their probability to develop the disease. We study the individual decisions to take the test and to undertake the prevention effort as a function of the effort cost and of its efficiency. If effort is observable by insurers, agents undertake the test only if the effort cost is neither too large nor too small. If the effort cost is not observable by insurers, moral hazard increases the value of the test if the effort cost is low. We offer several policy recommendations, from the optimal breadth of the tests to policies to do away with the discrimination risk. |
---|---|
ISSN: | 0167-6296 1879-1646 |
DOI: | 10.1016/j.jhealeco.2013.04.008 |